Bioethics, Ltd.
BOTH · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $33 | $39 | $23 | $27 |
| SG&A Expenses | $33 | $39 | $23 | $27 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $33 | $39 | $23 | $27 |
| Operating Income | -$33 | -$39 | -$23 | -$27 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$15 | -$14 | -$13 | -$12 |
| Pre-Tax Income | -$48 | -$53 | -$36 | -$40 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$48 | -$53 | -$36 | -$40 |
| % Margin | – | – | – | – |
| EPS | -0.015 | -0.047 | -0.032 | -0.035 |
| % Growth | 69% | -47.6% | 9.2% | – |
| EPS Diluted | -0.015 | -0.047 | -0.032 | -0.035 |
| Weighted Avg Shares Out | 3,335 | 1,135 | 1,135 | 1,135 |
| Weighted Avg Shares Out Dil | 3,335 | 1,135 | 1,135 | 1,135 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $15 | $14 | $13 | $12 |
| Depreciation & Amortization | -$89 | $39 | $23 | $27 |
| EBITDA | -$123 | $0 | $0 | $0 |
| % Margin | – | – | – | – |